Vaxart announces a successful Phase 2 influenza challenge study - and nothing happens! In theory, 40% of any rise should come onto AVIRs SP, but they got zero.
Amazing.
I think these guys have burnt all their fund manager bridges.
Add to My Watchlist
What is My Watchlist?